Pardon the interruption, but we are lawyers after all, so we need to make sure you understand that calling, or leaving a message does not establish an attorney-client relationship. Also, you need to know the information in your call will not be considered privileged or confidential unless, of course, we already represent you or have agreed to receive limited confidential material from you as a prospective client.
If you are a client, do not call with time-sensitive patent filing instructions and do not assume we have received or are acting upon your filing instructions unless you receive written confirmation from us.
If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference.
There, that wasn’t so bad, was it? Thank you for your interest in Wolf Greenfield.
Pardon the interruption, but we are lawyers after all, so we need to make sure you understand that sending an email does not establish an attorney-client relationship. Also, you need to know the information in your email will not be considered privileged or confidential unless, of course, we already represent you or have agreed to receive limited confidential material from you as a prospective client.
If you are a client, do not send time-sensitive patent filing instructions just to this email recipient. Also send to filinginstructions@wolfgreenfield.com and do not assume we have received or are acting upon your filing instructions unless you receive written confirmation from us.
If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference.
There, that wasn’t so bad, was it? Thank you for your interest in Wolf Greenfield.
Hunter Baker chairs the firm's Pharmaceutical Practice and has counseled clients for over 20 years in the life sciences, including pharmaceuticals, biologics, polymers, chemistry, and materials. Hunter counsels clients on patent prosecution, patentability searches, freedom-to-operate studies, opinion letters, IP diligences, and licensing.
Hunter has worked with clients ranging from academic institutions to start-ups to large pharmaceutical companies. He has also worked with clients in the financial industry in evaluating the IP involved in their investments.
Hunter completed his medical training at Harvard Medical School, where he was an MD-PhD student in the Harvard-MIT Division of Health Sciences and Technology, with his graduate work in Professor EJ Corey’s laboratory at Harvard University.
Hunter’s technical skills combined with his many years of experience practicing patent law in Boston allow him to craft the optimal IP strategy to meet his clients’ business goals.
Client Testimonials
Hunter's knowledge of [our patent portfolios] is indispensable. It's difficult to imagine where I'd be without [Wolf Greenfield].
Hunter knows that if I don’t respond to an email and it’s really important, he will call me. I am perfectly comfortable having him handle things without me if he needs to. He has never lost sight of who the client is and has a great perspective on working with us as a team.
Hunter is a preeminent lawyer in the field and has handled our matters impeccably. He always understands the science of the matter in a way that I do not, but can speak on the level with our staff. He and his team are a huge asset for us.
Experience
Drafted and prosecuted patent applications for academic institutions in areas of pharmaceuticals, drug delivery, materials, and biotechnology.
Counseled leading US cancer center on managing patent portfolio for new therapeutics currently undergoing clinical trials for use in treating cancer.
Managed patent portfolio covering technology for developing new clinical candidates.
Provided strategic advice to start-ups and medium-sized companies in developing patent portfolios for protecting lead drug candidates and extending patent exclusivity.
Developed and managed multiple patent portfolios for major universities, portfolios that have formed the basis of several start-ups in the life sciences, such as Tetraphase, Macrolide (now Zikani), Editas, Beam, Prime Medicine.
Provided IP diligence for major (>$100 million) transactions for financial investors.
Evaluated IP portfolios for venture capital firms seeking to make investments.
Activities
American Chemical Society
Boston Intellectual Property Law Association
Recognition
Hunter has repeatedly been named a “Life Science Star” by LMG Life Sciences. The LMG Life Sciences guide is based on case evidence and interviews with clients and peers from other law firms.
Hunter has been repeatedly named to the Massachusetts Super Lawyers list for his work in the field of intellectual property law. He has also been repeatedly named to Managing IP’s IP Stars list as a Massachusetts Patent Star and to The Best Lawyers in America®.
In addition, Hunter is ranked among the top 100 most active attorneys in biotech patent prosecution by Patexia in 2022.
